Literature DB >> 31741916

Clinical Patterns and Linear Growth in Children with Congenital Adrenal Hyperplasia, a 11 Year Experience.

Mahmood D Al-Mendalawi1.   

Abstract

Entities:  

Year:  2019        PMID: 31741916      PMCID: PMC6844163          DOI: 10.4103/ijem.IJEM_303_19

Source DB:  PubMed          Journal:  Indian J Endocrinol Metab        ISSN: 2230-9500


× No keyword cloud information.
Dear sir, I read with interest the distinguished study by Al Shaikh et al.[1] published in May-June 2019 issue of Indian Journal of Endocrinology and Metabolism. The authors studied the clinical pictures and evaluated linear growth and possible factors affecting it in Saudi children with congenital adrenal hyperplasia (CAH). On employing the World Health Organization (WHO) growth standard, they found that males had significantly decreased height standard deviations (HtSDS) versus females and females had significantly higher body mass index (BMI). The HtSDS of children who had had higher 17-hydroxy progesterone (17OHP) or salt-losing crisis during treatment was significantly lower than those who had normal 17OHP, and those who did not have salt-losing crisis, respectively.[1] The authors addressed two limitations that might pose some suspicions on the results of this study. These included the retrospective nature of the data and relatively small number of the studied CAH patients (n = 56). I assume that following methodological limitation might be additionally relevant. It is obvious that there are many growth standards employed to measure various anthropometric parameters, notably WHO standard, Center for Disease Control standard and country-specific standard. Evaluation of these standards revealed that the latter might describe more accurately the growth of children.[2] To my knowledge, L, M, and S parameters as well as Z scores were calculated for various anthropometric indices for Saudi children. These scores have been released for the precise assessment of nutrition and growth in the clinical settings and researches.[3] I wonder why Shaikh et al.[1] referred to WHO standard instead of the national Saudi standard to evaluate linear growth of the studied cohort. I assume that if they referred to the national standard in the study methodology, different results might be yielded. In the light of prevailing culturally-based consanguineous marriage in the Kingdom of Saudi Arabia[4] with the expectant surge in the prevalence of CAH in the foreseeable time, elaboration of Saudi-specific growth standard for CAH patients similar to that achieved in certain populations[5] is advocated.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  5 in total

1.  Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.

Authors:  Patricia Bretones; Benjamin Riche; Emmanuel Pichot; Michel David; Pascal Roy; Véronique Tardy; Behrouz Kassai; Ségolène Gaillard; Delphine Bernoux; Yves Morel; Pierre Chatelain; Marc Nicolino; Catherine Cornu
Journal:  J Pediatr Endocrinol Metab       Date:  2016-12-01       Impact factor: 1.634

2.  Is consanguinity prevalence decreasing in Saudis?: A study in two generations.

Authors:  Arjumand Sultan Warsy; May Hamad Al-Jaser; Abeer Albdass; Sooad Al-Daihan; Mohammad Alanazi
Journal:  Afr Health Sci       Date:  2014-06       Impact factor: 0.927

Review 3.  The WHO growth standards: strengths and limitations.

Authors:  Ekhard E Ziegler; Steven E Nelson
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-05       Impact factor: 4.294

4.  The LMS and Z scale growth reference for Saudi school-age children and adolescents.

Authors:  Mohammad I El Mouzan; Abdullah A Al Salloum; Mansour M Alqurashi; Abdullah S Al Herbish; Ahmad Al Omar
Journal:  Saudi J Gastroenterol       Date:  2016 Jul-Aug       Impact factor: 2.485

5.  Clinical Patterns and Linear Growth in Children with Congenital Adrenal Hyperplasia, an 11-Year Experience.

Authors:  Adnan Al Shaikh; Yasser AlGhanmi; Saniah Awidah; Abdullah Bahha; Mohamed E Ahmed; Ashraf T Soliman
Journal:  Indian J Endocrinol Metab       Date:  2019 May-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.